SQI Diagnostics Launches SQiDlite™ Multiplexing System at American Association of Pharmaceutical Scientists  
10/12/2012 9:46:46 AM

TORONTO--(BUSINESS WIRE)--SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that its global launch of its SQiDlite Multiplexing System will take place at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition taking place in Chicago IL, October 14-18. SQiDlite was developed to address the multiplex testing needs of clinical diagnostic laboratories, pharmaceutical drug development and Contract Research Organizations (CRO) performing bioanalytical and immunogenicity testing.